Found: 37
Select item for more details and to access through your institution.
Targeting AMPK in the treatment of malignancies.
- Published in:
- Journal of Cellular Biochemistry, 2012, v. 113, n. 2, p. 404, doi. 10.1002/jcb.23369
- By:
- Publication type:
- Article
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 606, doi. 10.1002/ajh.27231
- By:
- Publication type:
- Article
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. E233, doi. 10.1002/ajh.27005
- By:
- Publication type:
- Article
Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E327, doi. 10.1002/ajh.26250
- By:
- Publication type:
- Article
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E231, doi. 10.1002/ajh.25552
- By:
- Publication type:
- Article
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 111, doi. 10.1002/ajh.25333
- By:
- Publication type:
- Article
Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 213, doi. 10.1002/ajh.24974
- By:
- Publication type:
- Article
Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 964, doi. 10.1111/ejh.14192
- By:
- Publication type:
- Article
Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0804-6
- By:
- Publication type:
- Article
AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S285, doi. 10.1016/S2152-2650(21)01684-0
- By:
- Publication type:
- Article
AML-091: Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S280, doi. 10.1016/S2152-2650(21)01674-8
- By:
- Publication type:
- Article
Poster: AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S212, doi. 10.1016/S2152-2650(21)01329-X
- By:
- Publication type:
- Article
Poster: AML-091: Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S210, doi. 10.1016/S2152-2650(21)01314-8
- By:
- Publication type:
- Article
Ivosidenib (IVO; AG-120) in IDH1-Mutant Newly-Diagnosed Acute Myeloid Leukemia (ND AML): Updated Results from a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S220, doi. 10.1016/j.clml.2019.07.094
- By:
- Publication type:
- Article
Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S204, doi. 10.1016/j.clml.2018.07.057
- By:
- Publication type:
- Article
Case Study: Treatment Decisions in Secondary AML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S124, doi. 10.1016/j.clml.2017.08.058
- By:
- Publication type:
- Article
Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00677-7
- By:
- Publication type:
- Article
The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation–positive relapsed/refractory acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 797, doi. 10.1002/cam4.3652
- By:
- Publication type:
- Article
Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Regulatory Effects of Sestrin 3 (SESN3) in BCR-ABL Expressing Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0078780
- By:
- Publication type:
- Article
Patient‐reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 2, p. 287, doi. 10.1002/cncr.35021
- By:
- Publication type:
- Article
TP53‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 175, doi. 10.1002/cncr.34535
- By:
- Publication type:
- Article
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 23, p. 4421, doi. 10.1002/cncr.33828
- By:
- Publication type:
- Article
BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 8, p. 1246, doi. 10.1002/cncr.33338
- By:
- Publication type:
- Article
Therapy‐related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 6, p. 736, doi. 10.1111/bjh.18154
- By:
- Publication type:
- Article
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all- trans retinoic acid and arsenic trioxide.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 471, doi. 10.1111/bjh.13607
- By:
- Publication type:
- Article
Pevonedistat ( MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 4, p. 534, doi. 10.1111/bjh.13323
- By:
- Publication type:
- Article
F-18 FDG- PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 6, p. 793, doi. 10.1111/bjh.12824
- By:
- Publication type:
- Article
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 4, p. 497, doi. 10.1111/bjh.12775
- By:
- Publication type:
- Article
Two‐dimensional speckle‐tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.
- Published in:
- Echocardiography, 2019, v. 36, n. 11, p. 2033, doi. 10.1111/echo.14518
- By:
- Publication type:
- Article
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0249087
- By:
- Publication type:
- Article
Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092209
- By:
- Publication type:
- Article
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 105, doi. 10.1007/s00277-023-05552-4
- By:
- Publication type:
- Article
Novel Therapeutics Targeting CD19 and CD22 in Adult Acute Lymphoblastic Leukemia.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 1, p. 14
- By:
- Publication type:
- Article
Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-8722-7-36
- By:
- Publication type:
- Article